Neolife Statements
8J
Data from Neolife`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
EUR - Euro
Last reporting period:
30 Jun, 2023
Next reporting period:
27 Dec, 2023
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Neolife Income Statement
B
M
EUR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
7.505
-43.9 %
100
6.56
87.4
0.945
-41 %
12.6
—
0
1.096
14.6
1.319
-49.9 %
17.6
-0.374
63.7 %
-5
-0.012
-0.2
—
0
-0.387
89.4 %
-5.2
-0.011
-0.2
-0.375
89.6 %
-5.0006
-0.004
96.371
13.37
102.9 %
100
11.768
88
1.602
106.5 %
12
—
0
2.005
15
2.632
93.6 %
19.7
-1.03
-76.4 %
-7.7
0.385
2.9
—
0
-3.663
-490.1 %
-27.4
-0.038
-0.3
-3.625
-450.2 %
-27.1
-0.038
96.371
6.591
13.5 %
100
5.815
88.2
0.776
-29.2 %
11.8
—
0
1.313
19.9
1.36
34.8 %
20.6
-0.584
-766.4 %
-8.9
-0.012
-0.2
—
0
-0.621
-921.2 %
-9.4
0.038
0.6
-0.659
-1879.1 %
-10
-0.013
52.378
5.808
18.1 %
100
4.711
81.1
1.096
12.9 %
18.9
—
0
1.018
17.5
1.009
-4 %
17.4
0.088
211 %
1.5
-0.011
-0.2
—
0
0.076
148.9 %
1.3
0.039
0.7
0.037
117.9 %
0.6
0.001
53.068
4.917
16.2 %
100
3.946
80.2
0.971
24.5 %
19.8
—
0
1.035
21.1
1.05
12.9 %
21.4
-0.079
47.4 %
-1.6
-0.024
-0.5
—
0
-0.154
18.7 %
-3.1
0.052
1.1
-0.206
14 %
-4.2
-0.004
51.687
4.23
17.2 %
100
3.44
81.3
0.78
39.3 %
18.4
—
0
0.8
18.9
0.93
22.4 %
22
-0.15
25 %
-3.5
-0.05
-1.2
—
0
-0.19
9.5 %
-4.5
0.05
1.2
-0.24
11.1 %
-5.7
—
51.57
3.61
-10.6 %
100
3.05
84.5
0.56
—
15.5
—
0
0.66
18.3
0.76
-12.6 %
21.1
-0.2
35.5 %
-5.5
—
0
—
0
-0.21
48.8 %
-5.8
0.06
1.7
-0.27
41.3 %
-7.5
-0.01
51.69
4.04
-5.5 %
100
3.48
86.1
0.56
12.6 %
13.9
—
0
0.77
19.1
0.87
6.1 %
21.5
-0.31
4.1 %
-7.7
-0.03
-0.7
—
0
-0.41
-0.6 %
-10.1
0.06
1.5
-0.46
1.7 %
-11.4
-0.01
52.38
4.273
55.4 %
100
3.776
88.4
0.497
392.4 %
11.6
—
0
0.787
18.4
0.82
46.5 %
19.2
-0.323
55.7 %
-7.6
-0.028
-0.7
—
0
-0.407
49.7 %
-9.5
0.061
1.4
-0.468
45.6 %
-11
-0.011
40.691
2.75
-28.9 %
100
2.92
106.2
-0.17
-270 %
-6.2
—
0
0.67
24.4
0.56
-34.9 %
20.4
-0.73
2.7 %
-26.5
-0.04
-1.5
-0.46
-16.7
-0.81
11 %
-29.5
0.05
1.8
-0.86
14 %
-31.3
-0.03
33.15
3.87
14.2 %
100
3.76
97.2
0.1
132.3 %
2.6
—
0
0.94
24.3
0.86
30.3 %
22.2
-0.75
22.7 %
-19.4
-0.04
-1.03
-0.01
-0.3
-0.91
13.3 %
-23.5
0.09
2.3
-1
14.5 %
-25.8
-0.05
19.96
3.39
10.1 %
3.7
-0.31
-158.3 %
—
0.83
0.66
-9.6 %
-0.97
-14.1 %
-0.05
-0.03
-1.05
-15.4 %
0.12
-1.17
-21.9 %
-0.05
23.35
3.08
51 %
3.2
-0.12
57.1 %
—
0.9
0.73
14.1 %
-0.85
6.6 %
-0.05
-0.02
-0.91
7.1 %
0.07
-0.96
63.1 %
-0.05
19.12
2.04
-4.2 %
2.31
-0.28
-27.3 %
—
0.73
0.64
12.3 %
-0.91
-13.7 %
-0.05
-0.02
-0.98
-14 %
1.69
-2.6
-381.5 %
-0.18
14.54
2.13
17.7 %
2.36
-0.22
63.9 %
—
0.77
0.57
-6.6 %
-0.8
34.4 %
-0.05
-0.02
-0.86
31.7 %
-0.32
-0.54
23.9 %
-0.04
14.88
1.81
-9.5 %
2.42
-0.61
-10.9 %
—
0.82
0.61
-14.1 %
-1.22
3.2 %
-0.05
-0.02
-1.26
6 %
-0.48
-0.71
18.4 %
-0.05
15.47
2
—
2.55
-0.55
—
—
0.89
0.71
—
-1.26
—
-0.04
-0.02
-1.34
—
-0.47
-0.87
—
-0.06
13.95